10.20
BATS BZX Real-Time Price
As of 10:58am ET
 -0.04 / -0.39%
Today’s Change
3.59
Today|||52-Week Range
13.41
+59.13%
Year-to-Date

Today’s Trading

Previous close10.24
Today’s open10.14
Day’s range10.01 - 10.32
Volume45,596
Average volume (3 months)3,186,087
Market cap$1.5B
Data as of 10:58am ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+45.86%
Earnings growth (this year)-15.12%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+168.41%
P/E ratioNM
Price/Sales5.45
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.15-1.24%
NTLAIntellia Therapeutic...-0.26-1.19%
MYOVMyovant Sciences Ltd+0.16+0.77%
CRSPCRISPR Therapeutics ...-0.83-1.45%
Data as of 10:56am ET, 04/20/2018

Financials

Next reporting dateMay 4, 2018
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$115.4M
Annual profit (last year)-$96.0M
Net profit margin-83.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts